Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

127 results found

Use advanced search filters to refine your search

2 filters applied

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    Medtech Sector Faces New EU 'Green Deal' Recommendations

    MedTech Europe is championing a greener future, following the recent industry push for greener and digitalised medical devices and in vitro diagnostics that featured prominently...
    European UnionFood, Drugs, Healthcare, Life Sciences
    Osborne Clarke LLP
    Osborne Clarke LLP
  • Article

    Reversal Of Burden Of Proof Under Proposal For A New EU Product Liability Directive

    The European Commission (the "Commission") adopted the Proposal for the revision of the PLD (the "Proposal") in September 2022. The co-legislators—the Council of the European Union...
    European UnionConsumer Protection
    Jones Day
Jones Day
  • Article

    High-Risk AI Systems In Life Sciences Face Strict Regulatory Scrutiny From New EU Rules

    The risk categorisation of artificial intelligence (AI) systems can ensure its regulation is proportionate and effective, with the intensity and scope of the risks that AI systems can generate...
    European UnionFood, Drugs, Healthcare, Life Sciences
    Osborne Clarke LLP
    Osborne Clarke LLP
  • Article

    Nanomaterials In Masks? The New Belgian Saga That Reminds Us Of Many Legal Inconsistencies

    In the midst of the global COVID-19 pandemics, the Belgian government decided in June 2020 to distribute free protective cloth masks to the population.
    BelgiumCoronavirus (COVID-19)
    Gil Robles - San Bartolome & Partners
    Gil Robles - San Bartolome & Partners
  • Article

    Trends In Life Sciences M&A: Cybersecurity And AI Take Center Stage

    Complementary perspectives on the challenges and opportunities shaping healthcare M&A. In Belgium, the implementation of the EU's NIS2 Directive has elevated cybersecurity to a central concern...
    BelgiumTechnology
    Loyens & Loeff
    Loyens & Loeff
  • Article

    Europe—General Court Confirms Obligation To Prove Significant Benefit Over All Authorized Medicinal Products, Including Those Authorized After The Submission Of The Marketing Authorization Application For The Future (Orphan) Product

    On December 5, 2018, the General Court (Court) ruled in favor of the European Commission in a case brought by Bristol-Myers Squibb Pharma (BMS) ...
    European UnionFood, Drugs, Healthcare, Life Sciences
    Mayer Brown
    Mayer Brown
  • Article

    The New EU "Pharma Package:" EU Reaches Landmark Deal On Pharma Package

    On December 11, 2025, the Council of the European Union and the European Parliament reached provisional agreement on the long-awaited "Pharma Package".
    European UnionFood, Drugs, Healthcare, Life Sciences
    Crowell & Moring LLP
    Crowell & Moring LLP
  • Article

    Low-Risk AI Bears High Stakes For Digital Health In New EU Regulation

    At the heart of the new European regulation laying down harmonised rules on artificial intelligence (AI) is a focus on high-risk AI systems and their stringent governance.
    European UnionFood, Drugs, Healthcare, Life Sciences
    Osborne Clarke LLP
    Osborne Clarke LLP
  • Article

    State And Federal Food-Labeling Reforms Impose Unappreciated Complexities And Compliance Challenges

    Food product labels are under intense scrutiny from consumers, regulators, class action lawyers, and non-governmental organizations (NGOs).
    BelgiumFood, Drugs, Healthcare, Life Sciences
    Hogan Lovells
    Hogan Lovells
  • Article

    AI Literacy Becomes Mandatory For Life Sciences Across The EU

    The pharma and medtech sectors have a strategic window to implement AI literacy ahead of an August enforcement deadline.
    BelgiumFood, Drugs, Healthcare, Life Sciences
    Osborne Clarke LLP
    Osborne Clarke LLP
  • Article

    New EU AI Act Is Poised To Shape The Future For Life Sciences In Europe

    Negotiated with the Member States in December 2023, the EU Artificial Intelligence (AI) Act, the regulation laying down harmonised rules on the transformative technology...
    European UnionFood, Drugs, Healthcare, Life Sciences
    Osborne Clarke LLP
    Osborne Clarke LLP
  • Article

    The Impacts Of The EU Data Act On Medical And Health Devices Companies

    The EU Data Act will be applicable from September 12, 2025. Given the consequent steps that will be required to comply with the EU Data Act...
    European UnionFood, Drugs, Healthcare, Life Sciences
    Steptoe LLP
    Steptoe LLP
  • Article

    Hospital Mergers No Longer Subject To The Belgian Competition Authority's Prior Review

    For the past five years there has been an ongoing battle between the Belgian Competition Authority ("BCA") and the legislator about the BCA's competence...
    BelgiumAntitrust/Competition Law
    ALTIUS
    ALTIUS
  • Article

    Administration Presents Plans To Lower Drug Prices

    On May 11, 2018, President Trump and Department of Health and Human Services (HHS) Secretary Alex Azar delivered highly anticipated speeches regarding the Administration's plan to reduce drug prices.
    BelgiumFood, Drugs, Healthcare, Life Sciences
    Hogan Lovells
    Hogan Lovells
  • Article

    The EU Batteries Regulation: Taking Stock Of The New EU Battery Requirements

    More than a year ago, the EU Batteries Regulation (Regulation (EU) 2023/1542) entered into force. In approximately one year's time, the EU Batteries Regulation is set to repeal the 2006 Batteries Directive...
    European UnionEnvironment
    Crowell & Moring LLP
    Crowell & Moring LLP
  • Article

    The New EU "Pharma Package": Interplay With The Critical Medicines Act And Other Shortage Initiatives

    In this eighth alert in our weekly series on the EU Pharma Package, we continue our overview of initiatives with respect to security of supply and shortage prevention and mitigation.
    European UnionFood, Drugs, Healthcare, Life Sciences
    Crowell & Moring LLP
    Crowell & Moring LLP
  • Article

    The New EU "Pharma Package": The "Bolar" Exemption – A Comparison Of Commission/Parliament/Council Positions

    In this sixth alert in our weekly series on the EU Pharma Package, we focus on the proposals of the European Commission, European Parliament and Council of the EU for another topic with a highly debated scope and with diverging interpretations across EU Member States: the "Bolar" exemption.
    European UnionIntellectual Property
    Crowell & Moring LLP
    Crowell & Moring LLP
  • Article

    Life Sciences Patents Monthly Roundup—May 2026

    This month, at the Unified Patent Court (UPC), the Düsseldorf Local Division’s dismissal of Align Technology’s provisional measures application against Angelalign reinforces the applicant’s evidential...
    European UnionIntellectual Property
    A&O Shearman
    A&O Shearman
  • Article

    EU Geopolitical Risk Update - Key Policy & Regulatory Developments No. 119

    This regular alert covers key policy and regulatory developments related to EU geopolitical risks, including in particular, economic security, Russia's war against Ukraine, health threats, and cyber threats.
    European UnionTechnology
    Jones Day
    Jones Day
  • Article

    The New EU "Pharma Package": Access Conditionalities And Shortage Measures – A Comparison Of Commission/Parliament/Council Positions

    In this seventh alert in our weekly series on the Pharma Package, we will discuss the increasing focus on shortages of medicinal products in the EU and the prevention...
    BelgiumFood, Drugs, Healthcare, Life Sciences
    Crowell & Moring LLP
    Crowell & Moring LLP
  • Showing 101–120 of 127 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics